Disc Medicine received a Complete Response Letter from the FDA on February 13, 2026, rejecting its new drug application for bitopertin due to uncertainties requiring more evidence. This news caused the company's stock to fall 22% the same day. The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit to recover investor losses, offering compensation without upfront fees. Investors who purchased Disc Medicine securities may join the class action for possible compensation.
Synchrony Financial has partnered with OpenAI to integrate AI models into its consumer portals, aiming to improve online shopping experiences. This early-stage collaboration will help customers discover products, pay, earn rewards, and build loyalty ...
South Korea's Kbank, the country's first internet-only bank, has officially partnered with Ripple to pilot blockchain-based cross-border remittances, focusing on corridors like Korea-UAE and Korea-Thailand. This partnership aims to replace traditiona...
Rosen Law Firm is investigating potential securities claims against Barclays PLC following reports that Barclays may have provided misleading business information related to its exposure to a collapsed UK mortgage lender, Market Financial Solutions L...
Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. This legal inquiry could impact shareholders of the company if wrongdoing is found. Investors currently holding Manhatt...
Provenance Blockchain (HASH) surged 13.8% to $0.008427, leading gains in the crypto market due to growing interest in blockchain applications for traditional financial services. Other notable gainers include Venice Token, Morpho, POL, and Zcash, refl...
